
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1073 | 966 | 1061 | 1094 | 1663 | - |
Fund Return | 7.34% | -3.41% | 6.14% | 3.04% | 10.7% | - |
Place in category | 138 | 699 | 456 | 60 | 52 | - |
% in Category | 17 | 85 | 57 | 9 | 10 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
China Universal Consumer Industries | 11.54B | -1.99 | -11.69 | 9.81 | ||
China Universal Selective Mixed Sec | 8.97B | 2.49 | -9.04 | 7.31 | ||
China Universal Blue Chip Equity Fu | 4.28B | -0.53 | -9.14 | 7.87 | ||
China Universal Healthcare Serv mix | 3.92B | 6.98 | -10.89 | - | ||
China Universal Waiyan Gr Theme Eq | 3.47B | -3.24 | -2.01 | 3.44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HuaShang New Trend Selected mix | 9.2B | 3.47 | 5.04 | 20.26 | ||
Soochow Mobile Internet mix A | 4.69B | 7.04 | 13.52 | - | ||
Soochow Mobile Internet mix C | 4.69B | 7.00 | 13.29 | - | ||
QHKY New Economy Flexible Alloc Fd | 4.63B | -0.64 | -14.84 | 5.81 | ||
Fullgoal New Power Alloc A | 4.27B | -4.88 | -3.25 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 10.09 | 49.20 | +1.21% | |
Kelun Pharm A | CNE100000PW7 | 9.84 | 32.21 | -0.80% | |
Xizang Haisco Pharmaceutical A | CNE100001BC7 | 7.68 | 38.00 | -3.53% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 5.83 | 20.09 | -1.57% | |
Salubris Pharm A | CNE100000FW8 | 5.04 | 32.75 | -0.40% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review